Brown Advisory’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,191
| Closed | -$42.7K | – | 1273 |
|
|
2024
Q2 | $42.7K | Sell |
3,191
-2,731
| -46% | -$36.5K | ﹤0.01% | 1216 |
|
|
2024
Q1 | $275K | Sell |
5,922
-64
| -1% | -$2.97K | ﹤0.01% | 1091 |
|
|
2023
Q4 | $405K | Buy |
5,986
+880
| +17% | +$59.5K | ﹤0.01% | 981 |
|
|
2023
Q3 | $370K | Sell |
5,106
-1,008
| -16% | -$73K | ﹤0.01% | 976 |
|
|
2023
Q2 | $455K | Buy |
6,114
+1,982
| +48% | +$147K | ﹤0.01% | 932 |
|
|
2023
Q1 | $220K | Buy |
4,132
+18
| +0.4% | +$958 | ﹤0.01% | 1109 |
|
|
2022
Q4 | $278K | Buy |
4,114
+533
| +15% | +$36K | ﹤0.01% | 1043 |
|
|
2022
Q3 | $447K | Buy |
3,581
+248
| +7% | +$31K | ﹤0.01% | 885 |
|
|
2022
Q2 | $317K | Buy |
3,333
+2,208
| +196% | +$210K | ﹤0.01% | 945 |
|
|
2022
Q1 | $181K | Buy |
+1,125
| New | +$181K | ﹤0.01% | 1072 |
|